Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
121
-
122
-
123
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
124
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
125
-
126
-
127
-
128
Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
129
Effects of Kylo-0603 on body weight, organ weight, and body fat content.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
130
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
131
The trends of cholesterol metabolism-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
132
-
133
-
134
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
135
Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
136
After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
137
-
138
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
139
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
140
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”